Product

KN057

Aliases

KN057 dose Ⅱ, KN057 dose Ⅲ, KN057 doseⅠ

2 clinical trials

3 indications

Indication

Indication

Hemophilia A with inhibitor

Indication

Hemophilia B with Inhibitor

Clinical trial

An Open, Multicenter, Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Subcutaneous (SC) Doses of KN057 in Subjects With Hemophilia A or B, With or Without Inhibitors

Status: Recruiting, Estimated PCD: 2024-02-28

Clinical trial

A Randomized, Open-label Study to Evaluate the Efficacy and Safety of KN057 Injection Prophylaxis in Patients With Hemophilia A or B With Inhibitors

Status: Recruiting, Estimated PCD: 2025-10-15